Objectives
After participating in this educational activity, attendees should be able to:
1|Describe the purpose and key requirements of the Drug Supply Chain Security Act (DSCSA) as they apply to pharmacy practice
2|Identify characteristics and situations that may indicate a suspect or illegitimate drug product within the medication supply chain
3|Explain appropriate pharmacist actions for verification, documentation, quarantine, and escalation when a potential DSCSA concern is identified
Presenter(s):
Madalyn Dankocsik, PharmD
PGY2 Health-System Pharmacy Administration and Leadership Resident
Baystate Medical Center
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
|---|---|---|---|
| Madalyn Dankocsik, PharmD | Speaker | No relevant relationships with ineligible companies to disclose | No |
Session date:
11/09/2026 - 2:00pm to 3:00pm EST
Location:
Hybrid - Baystate Medical Center & Webinar
759 Chestnut Street
Springfield, MA
01199
United States
See map: Google Maps
Add to calendar:
- 1.00 ACPE Contact Hours
- 1.00 ACPE Technician contact hours
Facebook
X
LinkedIn
Forward